|
|
|
题名
|
作者
|
年代
|
出处
|
被引量
|
| 1 | Modulation of β-lactam resistance in Staphylococcus aureus by catechins and gallates显示文摘 | Paul D Stapleton Saroj Shah James C Anderson Yukihiko Hara Jeremy M.T Hamilton-Miller Peter W Taylor | 2004 | International Journal of Antimicrobial Agents2004，，5： | 2 |
| 2 | The prevalence of human papillomavirus type 58 in Chinese patients with cervical carcinoma and its influence on survival 显示文摘 | SHAH W HONGWEI C JIN Z | 2009 | Clin Oncol ( R Coll Radiol)2009，21，10： | 1 |
| 3 | Management of duodenal and pancreaticobiliary perforations associated with peri- ampullary endoscopic procedures显示文摘 | Knudson K Raeburn C D McIntyre R C Jr Shah R J Chen Y K Brown W R | 2008 | Am J Surg2008，196，： | 1 |
| 4 | Determining strong-motion duration of earthquakes 显示文摘 | MeCann M W Shah H C | 1979 | Bulletin of the Seismological Society of America1979，69，4： | 1 |
| 5 | Composition and activity of the microbial population in an acidic up land s oil and effects of liming显示文摘 | Shah Z Adams W A Haven C D V | 1990 | Soil Biology & Bi ochemistry1990，22，： | 1 |
| 6 | Placenta accrete: spec- trum of US and MR imaging findings显示文摘 | Baughman W C Corterille J E Shah R R | 2008 | Radiol Graphics2008，28，7： | 1 |
| 7 | Hydrogen sulfide protec- ted gastric epithelial cell from ischemia/reperfusion injury by Keapl s-sulfhydration, MAPK dependent anti-apeptosis and NF- kappaB dependent anti-inflammation pathway 显示文摘 | Guo C Liang F Shah Masood W | 2014 | Eur J Pharma- col2014，725，： | 1 |
| 8 | Excellent survival after sibling or unrelated donor stem cell transplantation for ehronie granulomatous disease 显示文摘 | MARTINEZ C A SHAH S SHEARER W T | 2012 | J Allergy Clin Immunol2012，129，1： | 1 |
| 9 | Exploiting Mobility for Energy Efficient Data Collection in Wireless Sensor Networks显示文摘 | JAIN S SHAH R C BRUNETTE W | 2006 | Mobile Networks and Applications2006，11，3： | 1 |
| 10 | Vertex method for computing functions of fuzzy variables显示文摘 | Dong W Shah H C | 1987 | Fuzzy Sets and Systems1987，24，： | 1 |
| 11 | Epidermoid cyst ofthe testis:areport of three cases and aanalysis of 141 cases from the world literature显示文摘 | Shah K H Maxted W C Chun B | | 0，，： | 1 |
| 12 | 显示文摘 | Shah S I Li W Huang C P | 2002 | PANS2002，99，10： | 1 |
| 13 | 'Near miss' death in obstructive sleep apnea:a critical care syndrome显示文摘 | SHAH A QIAN W | 1991 | Crit Care Med1991，19，9： | 1 |
| 14 | Al-TUD-1,stable mesoporous aluminas with high surface areas显示文摘 | Shah Z Jansen J C Zhou W | 2003 | Applied Catalysis A:General2003，254，2： | 1 |
| 15 | A Method to Predict Shrinkage Cracking of Concrete显示文摘 | Shah S P Ouyang C Marikunte S Yang W | 1998 | ACI Mater J1998，95，4： | 1 |
| 16 | Composition and Activity of the Microbial Population in an Acidic Upland Soil and Effects of Liming 显示文摘 | SHAH Z ADAMS W A HAVEN C D V | 1990 | Soil Biology& Biochemistry1990，22，： | 1 |
| 17 | Vertex method for computing functions of fuzzy variables显示文摘 | Dong W M Shah H C | 1987 | Fuzzy Sets and Systems1987，24，1： | 1 |
| 18 | Mechanism and Kinetics of Selected Hydrogen Transfer Reactions Typical of Coal Liquefaction显示文摘 | Cronauer D C Jewell D W Shah Y T | 1979 | Ind Eng Chem Fundam1979，18，： | 1 |
| 19 | Tranexamic acid for intracerebral haemorrhage within 2 hours of onset: protocol of a phase Ⅱ randomised placebo-controlled double-blind multicentre trial显示文摘Rationale Haematoma growth is common early after intracerebral haemorrhage(ICH),and is a key determinant of outcome.Tranexamic acid,a widely available antifibrinolytic agent with an excellent safety profile,may reduce haematoma growth.Methods and design Stopping intracerebral haemorrhage with tranexamic acid for hyperacute onset presentation including mobile stroke units(STOP-MSU)is a phase Ⅱ double-blind,randomised,placebo-controlled,multicentre,international investigator-led clinical trial,conducted within the estimand statistical framework.Hypothesis In patients with spontaneous ICH,treatment with tranexamic acid within 2 hours of onset will reduce haematoma expansion compared with placebo.Sample size estimates A sample size of 180 patients(90 in each arm)would be required to detect an absolute difference in the primary outcome of 20%(placebo 39%vs treatment 19%)under a two-tailed significance level of 0.05.An adaptive sample size re-estimation based on the outcomes of 144 patients will allow a possible increase to a prespecified maximum of 326 patients.Intervention Participants will receive 1 g intravenous tranexamic acid over 10 min,followed by 1 g intravenous tranexamic acid over 8 hours;or matching placebo.Primary efficacy measure The primary efficacy measure is the proportion of patients with haematoma growth by 24±6 hours,defined as either≥33%relative increase or≥6 mL absolute increase in haematoma volume between baseline and follow-up CT scan.Discussion We describe the rationale and protocol of STOP-MSU,a phase Ⅱ trial of tranexamic acid in patients with ICH within 2 hours from onset,based in participating mobile stroke units and emergency departments. | Nawaf Yassi Henry Zhao Leonid Churilov Bruce C V Campbell Teddy Wu Henry Ma Andrew Cheung Timothy Kleinig Helen Brown Philip Choi Jiann-Shing Jeng Annemarei Ranta Hao-Kuang Wang Geoffrey C Cloud Rohan Grimley Darshan Shah Neil Spratt Der-Yang Cho Karim Mahawish Lauren Sanders John Worthington Ben Clissold Atte Meretoja Vignan Yogendrakumar Mai Duy Ton Duc Phuc Dang Nguyen Thai My Phuong Huy-Thang Nguyen Chung Y Hsu Gagan Sharma Peter J Mitchell Bernard Yan Mark W Parsons Christopher Levi Geoffrey A Donnan Stephen M Davis | 2022 | Stroke & Vascular Neurology2022，7，2： | 1 |
| 20 | Exploiting mobility for energy efficient data collection in wireless sensor networks显示文摘 | Jain S Shah R C Brunette W | 2006 | Mobile Networks&Applications2006，11，3： | 1 |
您所在的机构暂未开通此部分的功能，请联系管理员